Transforming healthcare with evidence-based solutions

The adoption of the Lenus Diagnose pathway for Heart Failure was compared to the existing pathway, estimating trade-offs between the pathways in costs and outcomes. An economic evaluation, consisting of cost-consequence, cost-utility and budget impact analyses, were conducted. The value of potential efficiency gains for the National Health Service (NHS) was estimated in a Health Technology Assessment (HTA).

An evaluation of early supported discharge for patients with exacerbations of chronic obstructive pulmonary disease (COPD) in rural areas was conducted by NHS Highland. It conducted a 12-week feasibility study to see if we could deliver a safe, effective, patient-centred, early supported discharge (ESD) pathway using Lenus Health COPD Support Service delivered virtually to patients in the Highlands of Scotland.

The RECEIVER trial was devised to evaluate the Lenus COPD support service by determining if people with severe COPD would continue to utilize the co-designed patient web application throughout study follow-up and to explore the impact of this digital service on clinical outcomes with its adoption alongside routine care.

The DYNAMIC-ROSE clinical trial has evaluated the impact of the Lenus COPD Support Service on clinical outcomes and health care resource utilisation when patients are onboarded onto the service immediately after a severe COPD exacerbation. The study assesses the reproducibility of the positive outcomes observed in Glasgow in a different population and health system. Interim results confirm that significant reductions in emergency admission are repeatable.

A service evaluation of the scale-up cohort using the Lenus COPD Support Service since May 2020 has been conducted. Using an implementation-effectiveness methodology and the evaluation confirms sustained improvements in clinical outcomes in both a larger high-risk cohort of Lenus COPD service users (with a recent admission) followed up for up to 2 years, and in a lower-risk cohort of patients with COPD with no admissions in the year prior to service onboarding.